牛流行熱（BEF）ワクチン市場レポート：2030年までの動向、予測、競合分析

牛流行熱（BEF）ワクチンの動向と予測

世界の牛流行熱（BEF）ワクチン市場は、2024年から2030年にかけてCAGR 7.0％で成長すると予測されます。この市場の主な促進要因は、一過性の牛熱の症例数の増加、ワクチン製造における技術開発、製薬企業の需要増加です。世界の牛流行熱（BEF）ワクチン市場の将来は、医療機器企業、製薬産業、動物病院市場でのビジネスチャンスにより有望視されています。

牛流行熱（BEF）ワクチン市場の洞察

Lucintelの予測では、一過性の牛熱の有病率の高さと世界の牛の頭数の多さから、牛が予測期間中に最大の成長を遂げる見込みです。

北米は、動物医療用ワクチンの研究開発に多額の投資を行う企業が多数存在することから、予測期間中に最大の成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答している：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の牛流行熱（BEF）ワクチン市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の牛流行熱（BEF）ワクチン市場動向（2018-2023）と予測（2024-2030）
• タイプ別の世界の牛流行熱（BEF）ワクチン市場
  • 生ワクチン
  • 不活化ワクチン
  • その他
• 用途別の世界の牛流行熱（BEF）ワクチン市場
  • 牛
  • 水牛
  • その他
• 最終用途別の世界の牛流行熱（BEF）ワクチン市場
  • 医療機器企業
  • 製薬産業
  • 動物病院
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の牛流行熱（BEF）ワクチン市場
• 北米の牛流行熱（BEF）ワクチン市場
• 欧州の牛流行熱（BEF）ワクチン市場
• アジア太平洋の牛流行熱（BEF）ワクチン市場
• その他地域の牛流行熱（BEF）ワクチン市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • タイプ別の世界の牛流行熱（BEF）ワクチン市場の成長機会
  • 用途別の世界の牛流行熱（BEF）ワクチン市場の成長機会
  • 最終用途別の世界の牛流行熱（BEF）ワクチン市場の成長機会
  • 地域別の世界の牛流行熱（BEF）ワクチン市場の成長機会
• 世界の牛流行熱（BEF）ワクチン市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の牛流行熱（BEF）ワクチン市場の生産能力拡大
  • 世界の牛流行熱（BEF）ワクチン市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Zoetis Services
• Nutri Pharmax
• Octavoscene
• Kyoto Biken Laboratories
• Indian Immunologicals

Bavine Ephermal Fever Vaccine Trends and Forecast

The future of the global bavine ephermal fever vaccine market looks promising with opportunities in the medical device companies, pharmaceutical industries, and animal hospitals markets. The global bavine ephermal fever vaccine market is expected to grow with a CAGR of 7.0% from 2024 to 2030. The major drivers for this market are growing number of cases of transient bovine fever, technological developments in the creation of vaccines , and rising demand for pharmaceutical companies.

A more than 150-page report is developed to help in your business decisions.

Bavine Ephermal Fever Vaccine by Segment

The study includes a forecast for the global bavine ephermal fever vaccine by type, application, end use, and region.

Bavine Ephermal Fever Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Live Vaccines
• Killed Vaccines
• Others

Bavine Ephermal Fever Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Cattle
• Water Buffaloes
• Others

Bavine Ephermal Fever Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Medical Device Companies
• Pharmaceutical Industries
• Animal Hospitals
• Others

Bavine Ephermal Fever Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Bavine Ephermal Fever Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bavine ephermal fever vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bavine ephermal fever vaccine companies profiled in this report include-

• Zoetis Services
• Nutri Pharmax
• Octavoscene
• Kyoto Biken Laboratories
• Indian Immunologicals

Bavine Ephermal Fever Vaccine Market Insights

Lucintel forecasts that cattle is expected to witness largest growth over the forecast period due to high prevalence of bovine ephemeral fever in cattle and large population of cattle worldwide.

North America is expected to witness largest growth over the forecast period due to growing presence of large number of companies with large investment of research and development of vaccines for animal health care.

Features of the Global Bavine Ephermal Fever Vaccine Market

Market Size Estimates: Bavine ephermal fever vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Bavine ephermal fever vaccine market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Bavine ephermal fever vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, end use, and regions for the bavine ephermal fever vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bavine ephermal fever vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for bavine ephermal fever vaccine market?

Answer: The global bavine ephermal fever vaccine market is expected to grow with a CAGR of 7.0% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the bavine ephermal fever vaccine market?

Answer: The major drivers for this market are growing number of cases of transient bovine fever, technological developments in the creation of vaccines , and rising demand for pharmaceutical companies.

Q3. What are the major segments for bavine ephermal fever vaccine market?

Answer: The future of the global bavine ephermal fever vaccine market looks promising with opportunities in the medical device companies, pharmaceutical industries, and animal hospitals markets.

Q4. Who are the key bavine ephermal fever vaccine market companies?

Answer: Some of the key bavine ephermal fever vaccine companies are as follows:

• Zoetis Services
• Nutri Pharmax
• Octavoscene
• Kyoto Biken Laboratories
• Indian Immunologicals

Q5. Which bavine ephermal fever vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that cattle is expected to witness largest growth over the forecast period due to high prevalence of bovine ephemeral fever in cattle and large population of cattle worldwide.

Q6. In bavine ephermal fever vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness largest growth over the forecast period due to growing presence of large number of companies with large investment of research and development of vaccines for animal health care.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the bavine ephermal fever vaccine market by type (live vaccines, killed vaccines, and others), application (cattle, water buffaloes, and others), end use (medical device companies, pharmaceutical industries, animal hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bavine Ephermal Fever Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Bavine Ephermal Fever Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Bavine Ephermal Fever Vaccine Market by Type
  • 3.3.1: Live Vaccines
  • 3.3.2: Killed Vaccines
  • 3.3.3: Others
• 3.4: Global Bavine Ephermal Fever Vaccine Market by Application
  • 3.4.1: Cattle
  • 3.4.2: Water Buffaloes
  • 3.4.3: Others
• 3.5: Global Bavine Ephermal Fever Vaccine Market by End Use
  • 3.5.1: Medical Device Companies
  • 3.5.2: Pharmaceutical Industries
  • 3.5.3: Animal Hospitals
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Bavine Ephermal Fever Vaccine Market by Region
• 4.2: North American Bavine Ephermal Fever Vaccine Market
  • 4.2.2: North American Bavine Ephermal Fever Vaccine Market by End Use: Medical Device Companies, Pharmaceutical Industries, Animal Hospitals, and Others
• 4.3: European Bavine Ephermal Fever Vaccine Market
  • 4.3.1: European Bavine Ephermal Fever Vaccine Market by Application: Cattle, Water Buffaloes, and Others
  • 4.3.2: European Bavine Ephermal Fever Vaccine Market by End Use: Medical Device Companies, Pharmaceutical Industries, Animal Hospitals, and Others
• 4.4: APAC Bavine Ephermal Fever Vaccine Market
  • 4.4.1: APAC Bavine Ephermal Fever Vaccine Market by Application: Cattle, Water Buffaloes, and Others
  • 4.4.2: APAC Bavine Ephermal Fever Vaccine Market by End Use: Medical Device Companies, Pharmaceutical Industries, Animal Hospitals, and Others
• 4.5: ROW Bavine Ephermal Fever Vaccine Market
  • 4.5.1: ROW Bavine Ephermal Fever Vaccine Market by Application: Cattle, Water Buffaloes, and Others
  • 4.5.2: ROW Bavine Ephermal Fever Vaccine Market by End Use: Medical Device Companies, Pharmaceutical Industries, Animal Hospitals, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Bavine Ephermal Fever Vaccine Market by Type
  • 6.1.2: Growth Opportunities for the Global Bavine Ephermal Fever Vaccine Market by Application
  • 6.1.3: Growth Opportunities for the Global Bavine Ephermal Fever Vaccine Market by End Use
  • 6.1.4: Growth Opportunities for the Global Bavine Ephermal Fever Vaccine Market by Region
• 6.2: Emerging Trends in the Global Bavine Ephermal Fever Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Bavine Ephermal Fever Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bavine Ephermal Fever Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Zoetis Services
• 7.2: Nutri Pharmax
• 7.3: Octavoscene
• 7.4: Kyoto Biken Laboratories
• 7.5: Indian Immunologicals